Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nespresso and Swarovski Invite You to Make Every Coffee Moment Shine
-
Aalberts reports the progress of its share buyback programme 21 September – 25 September 2026
-
Wood Mackenzie: Europe's Power Sector Hits 80% Zero-Carbon Generation by 2030, But Misses Its Own Renewables Target
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
20 Years Reveal a Changing Luxury Market as West Vancouver Prices Double
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SENIOR PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT plc - Ordinary Shares
-
Form 8.5 (EPT/RI)-Tribal Group Plc
-
Sage unveils the Financial Symphony – a musical composition that reveals the hidden rhythms of business
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-SThree Plc
-
Man Group PLC : Form 8.3 - Spire Healthcare Group Plc
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Form 8.3 - Sthree
-
Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
-
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
-
Form-8.3 GOOCH & HOUSEGO PLC - 28 09 2026 - (CGWL)
-
PROPOSALS FOR THE INTRODUCTION OF AN OVERNIGHT RESTRIKE MECHANIC AND A DISCRETIONARY INDEX CHANGE MECHANIC IN RESPECT OF THE AFFECTED SECURITIES MEETING OF THE ETP SECURITYHOLDERS
-
Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 09 2026 - (CGWL)
-
Transaction in Own Shares
-
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
-
Lithia & Driveway (LAD) Schedules Release of Third Quarter 2026 Results
-
Lithia & Driveway (LAD) Schedules Release of Third Quarter 2026 Results
-
Teads and Koddi Announce Global Partnership to Advance Programmatic Access to Retail Media
-
52% of business travelers prioritize security when companies provide their connection, according to Holafly for Business
-
ANJAC HEALTH & BEAUTY LAUNCHES A DEDICATED OFFERING TO SUPPORT PATIENTS ON GLP-1 TREATMENTS
-
ANJAC HEALTH & BEAUTY LAUNCHES A DEDICATED OFFERING TO SUPPORT PATIENTS ON GLP-1 TREATMENTS
-
STARTRADER Raises Lloyd's of London Client Fund Insurance to USD 30 Million in Aggregate
-
STARTRADER Raises Lloyd's of London Client Fund Insurance to USD 30 Million in Aggregate
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Long Hours, Changing Postures: Sihoo to Showcase Next-Generation Ergonomic Office Chairs at ORGATEC 2026
-
Vaisala Corporation: Managers’ Transactions – Björklund, Elina
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Valetax Wins 'Outstanding Global Broker Achievement' Award at Forex Expo Dubai 2026
-
Valetax Wins 'Outstanding Global Broker Achievement' Award at Forex Expo Dubai 2026
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Vaisala launches Indigo Supervisor as data center monitoring shifts from coverage to scalability
-
Arco Vara AS entered into a preliminary agreement for the sale of a 75% stake in Botanica Lozen EOOD
-
Transactions in connection with share buy-back program
-
Three years and counting: How long critical vulnerabilities survive in industrial systems
-
More Than 60 Startup iGaming Operators Have Chosen Optimove Ignite+ in Its First 18 Months
-
Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
-
WEMADE Launches Web3 Roguelike Tower Defense Game Hellsquad Rrrush!: Stone Rush
-
SJ selects Icomera for fleet-wide satellite connectivity rollout across SJ 3000 trains
-
Nasdaq Calypso Launches Agentic Capabilities to Scale AI Adoption Across the Trade Lifecycle
-
Enza Zaden and Limagrain Vegetable Seeds join forces to advance durable ToBRFV resistance
-
Willis launches RiskIQ Nexus, giving organizations a single trusted view of risk and insurance data to drive greater value
-
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf
-
Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD
